Evidence map›Paper›PMID 39473870›Full record

ArticleFrontiers in nephrology2024

Proceedings of a membrane update symposium: advancements, scientific insights, and future trends for dialysis membranes for enhanced clinical outcomes in end stage kidney disease patients.

Christoph Wanner, Raymond Vanholder, Alberto Ortiz, Andrew Davenport, Bernard Canaud, Peter J Blankestijn, Rosalinde Masereeuw, Jeroen Peter Kooman, Giuseppe Castellano, Dimitrios Stamatialis and 8 more

Abstract read
In one paragraph

Article in Frontiers in nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Over 500 000 people on kidney replacement therapy in the European Union.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Review
  2. Review
  3. The Role of Online Hemodiafiltration in Contemporary Kidney Care.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christoph WannerRenal Research Unit, Department of Clinical Research and Epidemiology, University of Würzburg, Würzburg, Germany.
Raymond VanholderNephrology Section, Department of Internal Medicine and Pediatrics, University Hospital, Ghent, Belgium.
Alberto OrtizDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.
Andrew DavenportUCL Department of Nephrology, Royal Free Hospital, University College London, London, United Kingdom.
Bernard CanaudSchool of Medicine, University of Montpellier, Montpellier, France.
Peter J BlankestijnDepartment of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands.
Rosalinde MasereeuwDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Jeroen Peter KoomanDivision of Nephrology, Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, Netherlands.
Giuseppe CastellanoDepartment of Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Dimitrios StamatialisAdvanced Organ Bioengineering and Therapeutics-Technical Medical Centre, University of Twente, Enschede, Netherlands.
Sandip MitraManchester Academy of Health Sciences Centre, Manchester University Hospitals, University of Manchester, Manchester, United Kingdom.
Muriel GrootemanDepartment of Nephrology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Nephrology, Amsterdam, Netherlands.
Viktoria WeberDepartment for Biomedical Research, University for Continuing Education Krems, Krem, Austria.
Thomas EbertMedical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany.
Amira AbdelrasoulDivision of Biomedical Engineering, Department of Chemical and Biological Engineering, University of Saskatchewan, Saskatoon, SK, Canada.
Sonja SteppanFresenius SE & Co. KGaA, Bad Homburg, Germany.
Anna Rebecca ScheiweFresenius SE & Co. KGaA, Bad Homburg, Germany.
Peter StenvinkelDivision of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose of symposium: From September 6 - 8 2022, the Life/2022 Membrane Symposium was held in Frankfurt, Germany, and transmitted live to a worldwide internet audience. The event was part of the Life/Nephrology Campus initiative, a continuous educational platform for the nephrology community to expand knowledge and share expertise on contemporary topics in chronic kidney disease. We describe recent questions and advances in the field, and we underline challenges in the care of dialysis patients and opportunities for integration of new findings into clinical practice to improve patient outcomes in end stage kidney disease patients. Topics: Most patients with kidney failure are on maintenance hemodialysis (MHD). The scientific program of the symposium was developed around topics about the role, functional determinants, technical aspects, limitations, and clinical implications of membranes presently in use. International experts with clinical or technical expertise as well as scientific recognition within the nephrology community were asked to prepare their presentations based on their own experiences, perceptions, opinions, and sources of information. The symposium devoted a major portion to discussing novel approaches for improving membranes and treatment quality, including updates on innovative concepts that may could potentially transform the landscape of kidney replacement therapy for chronic kidney disease patients in the future. Implications: The intent was to provide insights into current attention points for healthcare professionals new to the field of MHD, and to test a unique forum for continuing medical education integrating physician and patient experiences to promote changes in clinical practice. Furthermore, the symposium premiered a specifically developed mixed reality holographic 3D model to demonstrate recent dialyzer innovation diminishing protein fouling on membrane surfaces. As a continuous online educational platform for scientific exchange, this Life/2022 event provided online learning opportunities with on-demand content, with all symposium lectures freely available on

Indexed as

biocompatibilitychronic kidney diseaseclinical impactdialysis membranesinnovationsciencetechnology

Identifiers

PMID39473870
PMCPMC11520239

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.